Peisajovich Sergio G, Epand Raquel F, Epand Richard M, Shai Yechiel
Department of Biological Chemistry, Weizmann Institute of Science, Rehovot, Israel.
Eur J Biochem. 2002 Sep;269(17):4342-50. doi: 10.1046/j.1432-1033.2002.03132.x.
The N-terminal fusion peptide of Sendai virus F1 envelope glycoprotein is a stretch of 14 amino acids, most of which are hydrophobic. Following this region, we detected a segment of 11 residues that are strikingly similar to the N-terminal fusion peptide. We found that, when anchored to the membrane by palmitoylation of its N-terminus, this segment (WT-palm-19-33) induces membrane fusion of large unilamellar liposomes to almost the same extent as a segment that includes the N-terminal fusion peptide. The activity of WT-palm-19-33 was dependent on its specific sequence, as a palmitoylated peptide with the same amino-acid composition but a scrambled sequence was inactive. Interestingly, two mutations (G7A and G12A) known to increase F1- induced cell-cell fusion, also increased the homology between the N-terminal fusion peptide and WT-palm-19-33. The role of the amino-acid sequence on the fusogenicity, secondary structure, and mechanism of membrane fusion was analyzed by comparing a peptide comprising both homologous segments (WT 1-33), a G12A mutant (G12A 1-33), a G7A-G12A double mutant (G7A-G12A 1-33), and a peptide with a scrambled sequence (SC 1-33). Based on these experiments, we postulate that replacement of Gly 7 and Gly12 by Ala increases the alpha helical content of the N-terminal region, with a concomitant increase in its fusogenic activity. Furthermore, the dissimilar abilities of the different peptides to induce membrane negative curvature as well as to promote isotropic 31P NMR signals, suggest that these mutations might also alter the extent of membrane penetration of the 33-residue peptide. Interestingly, our results serve to explain the effect of the G7A and G12A mutations on the fusogenic activity of the parent F1 protein in vivo.
仙台病毒F1包膜糖蛋白的N端融合肽是一段由14个氨基酸组成的序列,其中大部分是疏水氨基酸。在该区域之后,我们检测到一段由11个残基组成的片段,其与N端融合肽惊人地相似。我们发现,当通过其N端的棕榈酰化锚定在膜上时,该片段(WT-palm-19-33)诱导大单层脂质体膜融合的程度几乎与包含N端融合肽的片段相同。WT-palm-19-33的活性取决于其特定序列,因为具有相同氨基酸组成但序列混乱的棕榈酰化肽没有活性。有趣的是,已知增加F1诱导的细胞-细胞融合的两个突变(G7A和G12A)也增加了N端融合肽与WT-palm-19-33之间的同源性。通过比较包含两个同源片段的肽(WT 1-33)、G12A突变体(G12A 1-33)、G7A-G12A双突变体(G7A-G12A 1-33)和序列混乱的肽(SC 1-33),分析了氨基酸序列对膜融合的融合活性、二级结构和机制的作用。基于这些实验,我们推测用丙氨酸取代甘氨酸7和甘氨酸12会增加N端区域的α螺旋含量,并同时增加其融合活性。此外,不同肽诱导膜负曲率以及促进各向同性31P NMR信号的不同能力表明,这些突变也可能改变33个残基肽的膜穿透程度。有趣的是,我们的结果有助于解释G7A和G12A突变对体内亲本F1蛋白融合活性的影响。